1 / 42

Disorders of Consciousness: Individualized Assessment Methods

Disorders of Consciousness: Individualized Assessment Methods. John Whyte, MD, PhD Moss Rehabilitation Research Institute & Thomas Jefferson University. Topics to be Covered. Challenges to reaching accurate diagnoses and assessing recovery in VS/MCS

mirari
Télécharger la présentation

Disorders of Consciousness: Individualized Assessment Methods

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Disorders of Consciousness:Individualized Assessment Methods John Whyte, MD, PhD Moss Rehabilitation Research Institute & Thomas Jefferson University

  2. Topics to be Covered • Challenges to reaching accurate diagnoses and assessing recovery in VS/MCS • The role of standardized assessment procedures • The role of individualized assessment procedures • Case examples of individualized assessment protocols

  3. Assessment:Challenges to Accurate Assessment • Behavior is highly variable from hour to hour and day to day • Available indicators are generally very simple behaviors that may not be indicators of consciousness (e.g., blinking, eye movements) • Clinicians and caregivers are not objective “integrators” of a set of observations: memory limitations and emotional factors

  4. Case Examples of Assessment Difficulties: • Record review for medical legal purposes of a patient in treatment for over a year • Assessment of a patient living at home: VS, MCS, or higher level?

  5. Standardized Assessment Approaches • “Macro” assessment scales: • FIM • DRS • GOS/ GOS-E • All require an inference about level of consciousness but do not specify how to arrive at that inference • Considerable recovery is possible without major impact on scores

  6. Standardized Assessment Approaches (cont.) • Standardized assessment scales appropriate for VS/MCS patients • Coma Recovery Scale-Revised (CRS-R) • Coma Near Coma Scale • Western Neuro Sensory Stimulation Profile (WNSSP) • Disorders of Consciousness Scale (DOCs) • All are more fine-grained, sensitive to change • They vary in terms of how well indicators of consciousness are operationalized • Can a single assessment provide a diagnosis?

  7. Role of Standardized Assessment • “Macro” scales: for use in the acute stage when significant recovery is likely; useful for program evaluation, discharge and therapy planning, research • “Micro” scales: acutely, for use in conjunction with “macro” scales; post-acute for stand-alone use for diagnosis (particularly in the absence of promising behaviors), program evaluation, therapy planning

  8. Quantitative Individualized Assessment (QIA) • Based on the principles of single subject experimental design • Intended to answer specific clinical questions and clarify the meaning of particular behaviors that may be controversial (like those discussed in the case examples) • May provide a diagnosis (VS vs. MCS in the process) • Useful for monitoring the progress in those behaviors • Useful for guiding treatment approaches

  9. How Does QIA Address the Challenges to Accurate Assessment? • Variability • Standardize the assessment conditions • Increase the “sample size” • Simple behaviors of ambiguous significance • Develop appropriate experimental controls for non-conscious possibilities • Observer bias, memory limitations • Operationalize assessment conditions and response scoring • Check inter-rater reliability

  10. The QIA Process used in the MossRehab Responsiveness Program • Initial general clinical evaluation and observation of behaviors, elicit family beliefs • Team meeting to identify questions and clinical priorities • Develop individualized assessment protocol in pilot form • Revise the protocol if necessary • Formal data collection by all disciplines • Periodic data review, team discussion, termination or modification of protocol

  11. An Introductory Example

  12. Does the patient make arm movements in response to verbal commands? • The patient appears to move his arm to command inconsistently. • Hypothesis: The patient’s arm movements will occur more often after verbal commands than after silence or contrasting commands. • Define “arm movement”, standardize commands, positioning, initial arousal interventions

  13. Arm Movements to Verbal Command

  14. How Do We Select the Question(s)? • Perceived importance by family and team members • Logical sequence • Currently available behaviors

  15. How Do We Select the Specific Behaviors and Design the Control Conditions? • Review injury history, neuroimaging, other relevant studies (e.g., ERPs, EMGs, etc.) • Observe for behaviors that occur with some frequency but not extremely frequently • Consider possible reasons for failure other than unconsciousness (e.g., deafness, blindness, aphasia)

  16. Types of Evaluations Successfully Conducted • Patterns of alertness and sleep • Patterns of restlessness and agitation • Visual status • Language comprehension and ability to follow commands • Ability to engage in simple communication tasks

  17. Successful Evaluations (cont.) • Types of cuing that result in the best performance • Ability to persist in tasks and whether specific types of cues can promote persistence • Whether certain types of grimacing or moaning are indications of pain • Whether patients recognize family members and/or respond to emotional themes

  18. Some Additional Case Examples

  19. Is the patient’s kicking spontaneous or related to the environment? • The patient had spontaneous kicking of both legs. • Hypothesis: The patient’s kicking is volitional and related to visual recognition of objects that can be kicked.

  20. Responding to Environmental Cues

  21. Can the patient see? • The patient appears to intermittently fixate and track visual stimuli. • Hypothesis: If the patient can see, she should orient to a visual stimulus more often than to nothing, and should orient more often to a complex visual stimulus than a simple one.

  22. Visual Assessment

  23. Can the patient use finger and thumb movements for Yes/No communication? • The patient can flex R thumb and index finger independently, reasonably consistently on command to “Show me a Yes” or “Show me a No” • Hypothesis: If the patient can use these finger movements to communicate, there should be a relationship between yes/no finger movements, and correct answers to yes/no questions

  24. Yes/No Communication

  25. Evaluation of Treatment Effects • No treatments are proven to enhance recovery. • Can we use the RP assessment methods to prove the value of treatments for individual patients? • We hoped to use the same single subject assessment methods to answer these questions about whether a drug or other treatment improves performance.

  26. Challenges to Individualized Assessment of Treatment • Variability of performance • Spontaneous recovery • Time taken for certain treatments to work • Short length of stay

  27. Three Basic Assessment Designs • A-B • A-B-A • A-B-A-B-A-B-A-B-A… • (where A = no treatment; B = treatment of interest)

  28. A-B Design PERFORMANCE TIME (DAYS)

  29. A-B-A Design PERFORMANCE TIME (DAYS)

  30. A-B-A-B-A-B Design PERFORMANCE TIME (DAYS)

  31. How Successfully Can We Evaluate Treatment Effects? • A-B: almost never • A-B-A: rarely done and rarely conclusive • A-B-A-B-A-B…: strongest design, but not feasible with most treatments; many treatment reversals may be needed if there is great variability

  32. Meta-Analysis of a Set of QIA Assessments in VS/MCS Patients • R. Martin, J. Whyte (in press)

  33. A-B-A-B:Methylphenidate & Responding

  34. A-B-A-B:Methylphenidate and Accuracy

  35. Management Structure • Typical interdisciplinary team responsible for patient treatment (including many other medical and physical priorities) • Assessment support team: specially trained Neuropsychologist, data clerk, working in collaboration with JW. • QAI team leads protocol design in collaboration with clinical team; all team members collect data • Reporting back to team with group decisions about next steps

  36. Conclusion • QIA methods are highly successful in assessment • QIA methods, within the reality constraints of the inpatient unit, and LOS, rarely produce definitive results re: treatment • QIA methods can answer specific questions of clinical concern, not answered by standardized scales; may be used in conjunction with those scales • We must rely on traditional group studies to advance our knowledge of treatment efficacy for this patient population

  37. References • Whyte J, DiPasquale M: Assessment of vision and visual attention in minimally responsive brain injured patients. Arch Phys Med Rehabil 76(9):804-810, 1995 • Phipps E, DiPasquale M, Blitz C, Whyte J: Interpreting responsiveness in persons with severe traumatic brain injury: beliefs in families and quantitative evaluations. J Head Trauma Rehabil 12(4):52-67, 1997 • Laborde A, Whyte J: Update on Pharmacology. Two dimensional, quantitative data analysis: its role in assessing the functional utility of psychostimulants in minimally conscious patients. J Head Trauma Rehabil 12(4):90-92, 1997 • Whyte J, Laborde A, DiPasquale MC: Assessment and treatment of the vegetative and minimally conscious patient. In Rosenthal M, Griffith ER, Kreutzer JS, Pentland B (eds.), Rehabilitation of the Adult and Child With Traumatic Brain Injury (3rd Ed.), Philadelphia: F.A. Davis, 25:435-452, 1999 • Phipps E, Whyte J: Medical decision-making with persons who are minimally conscious. Am J Phys Med Rehabil 78(1):77-82, 1999 • Whyte J, DiPasquale M., Vaccaro M: Assessment of command-following in minimally conscious brain injured patients. Arch Phys Med Rehabil 80:1-8, 1999

  38. References (cont.) • Giacino J, Ashwal S, Childs N, Cranford R, Jennett B, Katz D, Kelly J, Rosenberg J, Whyte J, Zafonte R, Zasler N: The minimally conscious state: Definition and diagnostic criteria. Neurology 12;58(3):349-353, 2002 • Whyte J:Valutazione quantitative dei pazienti in stato vegetativo o minimamente responsive “Quantitative assessment of vegetative and minimally conscious patients”. MR Giornale Italiano Di Medicina Riabilitativa, 17(4):31-37, 2003 • Giacino JT, Kalmar K, Whyte J: The JFK coma recovery scale-revised: measurement characteristics and diagnostic utility. Arch Phys Med Rehabil, 85(12):2020-2029, 2004 • Giacino J, Whyte J: The vegetative and minimally conscious states: current knowledge and remaining questions. The J Head Trauma Rehabil, 20;(1):30-50, 2005 • Whyte J,Katz D, Long D, DiPasquale MC, Polansky M, Kalmar K, Giacino J, Childs N, Mercer W, Novak P, Maurer P, Eifert B: Predictors of outcome and effect of psychoactive medications in prolonged posttraumatic disorders of consciousness: A multicenter study. Arch Phys Med Rehabil, 86;(3):453-462, 2005 • Martin RT, Whyte J: The effects of methyphenidate on command following and yes/no communication in persons with severe disorders of consciousness: a meta-analysis of n-of-1 studies. Am J Phys Med Rehabil (in press)

  39. General Discussion

  40. A Multicenter Prospective Randomized Controlled Trial of the Effectiveness of Amantadine Hydrochloride in Promoting Recovery of Function Following Severe Traumatic Brain Injury: “The Amantadine Study”

  41. Study Participants • Participants: patients with traumatic brain injuries resulting in severe disorders of consciousness • 180 participants, across 8 facilities in the United States and Europe.

  42. Aims of the study • To determine whether amantadine improves functional recovery in patients with severe disorders of consciousness • To determine whether any amantadine-related gains in function are maintained after the drug is discontinued

More Related